XML 48 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
OPERATING SEGMENTS (Tables)
9 Months Ended
Sep. 30, 2022
OPERATING SEGMENTS  
Schedule of financial information for each of the entity's reportable segments, including the impact of the preceding changes on previously reported full year 2021 net sales and operating income

December 31, 2021

  

  

  

  

2021 Reported

Fixed

2021 Reported

Valued at 2021

  

  

Currency

  

Valued at 2022

(millions)

Management Rates

  

Other

  

Rate Change

  

Management Rates

Net Sales

  

  

  

Global Industrial

$6,304.9

$-

($218.1)

$6,086.8

Global Institutional & Specialty

3,978.2

-

(69.4)

3,908.8

Global Healthcare & Life Sciences

1,195.4

-

(45.8)

1,149.6

Other

1,226.9

-

(25.9)

1,201.0

Corporate

139.4

-

(2.0)

137.4

Subtotal at fixed currency rates

12,844.8

-

(361.2)

12,483.6

Effect of foreign currency translation

(111.7)

-

361.2

249.5

Consolidated reported GAAP net sales

$12,733.1

$-

$-

$12,733.1

Operating Income

Global Industrial

$1,031.0

$4.0

($49.3)

$985.7

Global Institutional & Specialty

556.9

(3.8)

(7.4)

545.7

Global Healthcare & Life Sciences

160.9

(0.9)

(7.7)

152.3

Other

187.3

0.7

(4.0)

184.0

Corporate

(318.6)

2.0

(316.6)

Subtotal at fixed currency rates

1,617.5

-

(66.4)

1,551.1

Effect of foreign currency translation

(18.9)

66.4

47.5

Consolidated reported GAAP operating income

$1,598.6

$-

$-

$1,598.6

Schedule of financial information for each of the entity's reportable segments

Third Quarter Ended 

Nine Months Ended 

September 30

September 30

(millions)

    

2022

2021

2022

2021

Net Sales

Global Industrial

 

$1,816.7

$1,565.0

$5,077.8

$4,452.2

Global Institutional & Specialty

1,183.2

1,057.1

3,323.4

2,864.7

Global Healthcare & Life Sciences

375.5

279.7

1,138.9

852.8

Other

362.1

319.5

1,000.4

885.2

Corporate

27.8

35.4

96.4

102.7

Subtotal at fixed currency rates

3,765.3

3,256.7

10,636.9

9,157.6

Effect of foreign currency translation

(96.0)

64.1

(120.3)

210.9

Consolidated reported GAAP net sales

 

$3,669.3

 

$3,320.8

$10,516.6

$9,368.5

Operating Income

Global Industrial

 

$277.0

$258.6

$693.2

$719.7

Global Institutional & Specialty

199.1

190.9

462.5

390.5

Global Healthcare & Life Sciences

34.7

35.2

137.3

123.9

Other

64.4

57.8

153.6

140.9

Corporate

(77.2)

(89.4)

(264.7)

(202.8)

Subtotal at fixed currency rates

498.0

453.1

1,181.9

1,172.2

Effect of foreign currency translation

(15.0)

12.7

(18.6)

38.7

Consolidated reported GAAP operating income

 

$483.0

 

$465.8

$1,163.3

$1,210.9